Reitz Capital Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-854
| Closed | -$126K | – | 25 |
|
|
2023
Q3 | $126K | Buy |
+854
| New | +$126K | 0.24% | 27 |
|
|
2023
Q2 | – | Sell |
-1,411
| Closed | -$225K | – | 48 |
|
|
2023
Q1 | $225K | Sell |
1,411
-135
| -9% | -$21.5K | 0.21% | 45 |
|
|
2022
Q4 | $250K | Sell |
1,546
-100
| -6% | -$16.2K | 0.24% | 43 |
|
|
2022
Q3 | $221K | Sell |
1,646
-88
| -5% | -$11.8K | 0.2% | 44 |
|
|
2022
Q2 | $266K | Sell |
1,734
-1,122
| -39% | -$172K | 0.24% | 42 |
|
|
2022
Q1 | $463K | Sell |
2,856
-213
| -7% | -$34.5K | 0.34% | 32 |
|
|
2021
Q4 | $346K | Sell |
3,069
-250
| -8% | -$28.2K | 0.24% | 34 |
|
|
2021
Q3 | $358K | Buy |
3,319
+250
| +8% | +$27K | 0.27% | 30 |
|
|
2021
Q2 | $346K | Sell |
3,069
-150
| -5% | -$16.9K | 0.24% | 34 |
|
|
2021
Q1 | $348K | Buy |
3,219
+985
| +44% | +$106K | 0.26% | 35 |
|
|
2020
Q4 | $239K | Buy |
+2,234
| New | +$239K | 0.19% | 46 |
|
|
2020
Q3 | – | Sell |
-1,582
| Closed | -$156K | – | 49 |
|
|
2020
Q2 | $156K | Buy |
+1,582
| New | +$156K | 0.2% | 37 |
|